Cuprina Holdings is trading at $2.08, up 6.41%, with no clear company-specific catalyst identified for the September 29 move. - The latest company news found was the September 17 closing of its public offering; it does not establish a reason for this session’s gain. - Crypto prices show modest gains, but company materials describe Cuprina as a biomedical company, not a crypto-related business. - Major indices are nearly flat in the supplied market context, which does not clearly account for the rise.